Published in Nature Communications: MiNK Therapeutics’ AgenT-797 Demonstrates Promising Results in the Treatment of Severe Acute Respiratory Distress
February 6, 2024
0
MiNK Therapeutics in the NEWS Today, February 6, 2024, MiNK Therapeutics (INKT) announced the publication of the results in Nature Communications from phase 1/2 study of agenT-797 . . . This content is for paid subscribers. Please click here to subscribe or here to log in.